Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.

[1]  M. Niemelä,et al.  Blood Transfusion and Outcome After Transfemoral Transcatheter Aortic Valve Replacement. , 2019, Journal of cardiothoracic and vascular anesthesia.

[2]  A. Sannino,et al.  Comparison of Baseline Characteristics and Outcomes in Men Versus Women With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. , 2018, The American journal of cardiology.

[3]  S. Bagshaw,et al.  Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery , 2017, The New England journal of medicine.

[4]  F. Mohr,et al.  Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI). , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  J. Webb,et al.  Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. , 2017, JACC. Cardiovascular interventions.

[6]  A. Regueiro,et al.  Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  D. Sorysz,et al.  Association Between Blood Transfusions and 12-Month Mortality After Transcatheter Aortic Valve Implantation. , 2017, International heart journal.

[8]  G. Dangas,et al.  Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. , 2016, Journal of the American College of Cardiology.

[9]  A. Pichard,et al.  Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. , 2016, The American journal of cardiology.

[10]  Y. Arbel,et al.  Impact of Hemoglobin Drop, Bleeding Events, and Red Blood Cell Transfusions on Long-term Mortality in Patients Undergoing Transaortic Valve Implantation. , 2016, The Canadian journal of cardiology.

[11]  Samin K. Sharma,et al.  Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. , 2016, JACC. Cardiovascular interventions.

[12]  M. Mack,et al.  Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement , 2016, Annals of Internal Medicine.

[13]  M. Leon,et al.  Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients. , 2015, Journal of the American College of Cardiology.

[14]  L. Pierelli,et al.  A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single‐blind randomized controlled trial , 2015, Transfusion.

[15]  M. Mack,et al.  Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.

[16]  F. Santini,et al.  Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. , 2014, The Journal of thoracic and cardiovascular surgery.

[17]  J. Maessen,et al.  Prevalence, Factors Associated With, and Prognostic Effects of Preoperative Anemia on Short- and Long-Term Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation , 2013, Circulation. Cardiovascular interventions.

[18]  J. Bavaria,et al.  Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. , 2012, Journal of the American College of Cardiology.

[19]  P. Serruys,et al.  Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. , 2012, American heart journal.

[20]  Y. Yoo,et al.  Effect of Single Recombinant Human Erythropoietin Injection on Transfusion Requirements in Preoperatively Anemic Patients Undergoing Valvular Heart Surgery , 2011, Anesthesiology.

[21]  P. Serruys,et al.  Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[22]  H. Baumgartner,et al.  Gender differences in clinical presentation and surgical outcome of aortic stenosis , 2010, Heart.

[23]  F. Crea,et al.  Sex-related differences in myocardial remodeling. , 2010, Journal of the American College of Cardiology.

[24]  Meng Xu,et al.  The Impact of Gender on In-Hospital Mortality and Morbidity After Isolated Aortic Valve Replacement , 2006, Anesthesia and analgesia.

[25]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[26]  T. Yamada,et al.  Autologous blood donation with recombinant human erythropoietin in anemic patients. , 1999, The Annals of thoracic surgery.